Cryptyx Bioscience is a princeton-based biopharmaceutical platform company.
Cryptyx Bioscience is a genetics-free, cloning-free, bioactivity-first platform for accessing hidden therapeutic natural products encoded in bacteria. They utilize a natural product drug discovery platform aimed at activating silent biosynthetic gene clusters in bacteria and at unlocking the full potential of any culturable microbe.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 21, 2022 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |